Understanding Osler-Weber-Rendu Syndrome (HHT) and the Role of Radiology

What is Osler-Weber-Rendu Syndrome (HHT)?

Osler-Weber-Rendu syndrome, also known as hereditary hemorrhagic telangiectasia (HHT), is a rare inherited genetic disorder that affects the blood vessels. In individuals with HHT, there are abnormal connections between arteries and veins in various organ systems. These abnormal connections, called arteriovenous malformations (AVMs), can lead to a range of symptoms, including telangiectasias (small, dilated blood vessels visible on the skin and mucous membranes) and internal bleeding. HHT can affect multiple parts of the body, including the brain, lungs, liver, and gastrointestinal tract. The severity of HHT can vary greatly from person to person, even within the same family.

Key Characteristics of HHT:

• Genetic Basis: Most people with HHT have a known genetic mutation. However, in some families, the specific mutation may not be identified, making genetic testing alone insufficient to rule out the condition.
• Blood Vessel Abnormalities: The hallmark of HHT is the formation of AVMs, which are direct links between arteries and veins, bypassing the capillary system. These AVMs are fragile and prone to bleeding.
• Organ Involvement: AVMs can develop in various organs, leading to different symptoms depending on the location and size of the malformations.

Symptoms of Osler-Weber-Rendu Syndrome

The symptoms of HHT can vary widely and may not appear until later in life. Some individuals may have very mild symptoms or none at all, while others experience severe complications. The most common symptoms include:

Nosebleeds (Epistaxis)

Recurrent and often severe nosebleeds are the most common symptom, affecting at least 95% of people with HHT. These can start at any age but often become more frequent and problematic in adulthood.

Gastrointestinal (GI) Bleeding

About 15% to 20% of people with HHT experience recurrent GI bleeding, typically starting in their 20s. This bleeding often originates from AVMs or telangiectasias in the stomach or intestines. While endoscopy can detect many GI AVMs and telangiectasias, medical imaging plays a role in assessing larger or deeper lesions.

Brain AVMs

Approximately 10% of individuals with HHT develop AVMs in the brain. These can lead to serious complications such as seizures or strokes. MRI is the preferred imaging technique for detecting brain AVMs.

Lung AVMs

Lung AVMs occur in at least 50% of HHT cases. These abnormal connections in the lungs can cause shortness of breath, fatigue, or stroke-like symptoms if blood clots or air bubbles bypass the lungs and enter the systemic circulation. A "bubble study" (an agitated saline injection followed by observation for bubbles in the heart) is often the initial screening test for lung vascular malformations. Chest CT scans are used for monitoring.

Liver AVMs

While AVMs in the liver can occur in up to 75% of people with HHT, they often do not cause symptoms. When they do cause problems, they can lead to heart failure or portal hypertension.

Skin and Mucous Membrane Telangiectasias

These are small, red, spider-like blood vessels that can appear on the face, lips, tongue, and hands. They are usually not a cause for concern in terms of bleeding but are a diagnostic clue.

Diagnosis of HHT

Diagnosing HHT typically involves a combination of clinical evaluation, family history, and medical imaging. Doctors often use the Curaçao criteria to diagnose HHT:

The Curaçao Criteria:

• Spontaneous, recurrent nosebleeds
• Telangiectasias on the lips, tongue, or hands
• Internal AVMs (in the brain, lungs, or liver)
• A first-degree relative with a confirmed diagnosis of HHT

A person is considered to have definite HHT if they meet at least three of these four criteria. Meeting two criteria suggests a "probable" diagnosis. For individuals with a family history of HHT or those who meet some criteria, screening medical imaging is crucial for detecting internal AVMs.

The Role of Radiology in Diagnosis

Medical imaging, including MRI, CT scans, and ultrasound, plays a critical role in diagnosing HHT. These techniques allow doctors to visualize and identify AVMs in various organs that may not be apparent through physical examination alone.

• MRI: Particularly useful for detecting brain AVMs. MR angiography with contrast can enhance the visualization of abnormal blood vessels.
• CT Scans: Used to screen for and monitor lung AVMs. A chest CT can provide detailed images of the pulmonary vasculature.
• Ultrasound: May be used in certain situations, particularly for evaluating liver AVMs.
• Bubble Study: An initial screening test for lung AVMs, involving injecting agitated saline into a vein and observing for bubbles in the heart.

Treatment for Osler-Weber-Rendu Syndrome

There is no cure for HHT, but treatments focus on managing symptoms, preventing complications, and improving quality of life. Treatment plans are individualized based on the specific manifestations of the disease in each patient.

Managing Bleeding

• Nosebleeds: Treatments can include nasal sprays, cauterization, and in severe cases, surgical interventions.
• GI Bleeding: Endoscopic treatments and sometimes embolization (blocking off abnormal blood vessels) may be used.

Treating AVMs

When AVMs pose a significant risk of bleeding or other complications, treatment may be necessary. Radiology plays a key role in guiding these interventions:

• Embolization: A minimally invasive procedure where a catheter is used to deliver tiny coils or other materials to block off the feeding artery of an AVM, reducing blood flow and the risk of rupture. This is often performed under imaging guidance.
• Surgery: In some cases, surgical removal of AVMs may be considered, especially for brain AVMs that cannot be treated with embolization.

Monitoring with Imaging

Regular imaging studies are essential for monitoring the status of known AVMs and detecting new ones. For example, small lung AVMs might be monitored with chest CT scans every 3 to 5 years. The decision to intervene is based on the size, location, and risk factors associated with the AVM, as determined by imaging.

Prevention and Lifestyle

While HHT is a genetic condition and cannot be prevented, proactive management and lifestyle adjustments can help minimize complications:

• Avoidance of certain medications: Non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen and aspirin can increase the risk of bleeding and should generally be avoided unless prescribed by a doctor.
• Regular medical check-ups: Consistent follow-up with healthcare providers specializing in HHT is crucial for early detection and management of complications.
• Healthy lifestyle: Maintaining a balanced diet and engaging in moderate physical activity can support overall health, but strenuous activities that could increase blood pressure should be discussed with a doctor.
• Iron supplementation: Due to chronic blood loss, iron deficiency anemia is common. Regular monitoring and iron supplementation may be necessary.

When to Consult a Doctor

It is important to seek medical attention if you experience any of the following:

• Frequent or severe nosebleeds that do not stop with simple measures.
• Any signs of internal bleeding, such as blood in your stool or vomit, or unexplained fatigue and weakness.
• Neurological symptoms like severe headaches, dizziness, vision changes, or weakness on one side of the body, which could indicate a brain AVM complication.
• Shortness of breath or chest pain.
• A family history of HHT or unexplained bleeding disorders.

Early diagnosis and consistent management are key to living well with Osler-Weber-Rendu syndrome. Radiology plays an indispensable role in this process, providing crucial insights for diagnosis, monitoring, and guiding treatment decisions.

Additional Medical Guidance

This section adds practical context and preventive advice to help readers make informed healthcare decisions. It is important to verify symptoms early, consult qualified doctors, and avoid self-medication for persistent health issues.

Maintaining healthy routines, following prescribed treatment plans, and attending regular checkups can improve outcomes. If symptoms worsen or red-flag signs appear, immediate medical evaluation is recommended.

Quick Checklist

• Track symptoms and duration.

• Follow diagnosis and treatment from a licensed practitioner.

• Review medication side effects with your doctor.

• Seek urgent care for severe warning signs.